Vincere Biosciences is a JLABS incubator company whose mission is to develop drugs to halt the progression of Parkinson's disease (PD).
Vincere Biosciences has raised $2.7M in total funding. The most recent round was Grant. The last funding was announced in September 2026.
Vincere Biosciences's investors include Alumni Ventures, Draper Associates, Michael J. Fox Foundation, Portal Innovations, Daewoong Pharmaceutical.
Vincere Biosciences is headquartered in Cambridge, United States.
Vincere Biosciences is a JLABS incubator company whose mission is to develop drugs to halt the progression of Parkinson's disease (PD).
Vincere Biosciences is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vincere Biosciences — Funding & Investors." VCBacked, September 10, 2026, https://www.vcbacked.co/company/vincere-biosciences. Accessed October 31, 2026.
VCBacked. (2026). Vincere Biosciences — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/vincere-biosciences
{{cite web |title=Vincere Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/vincere-biosciences |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated